| Daria Denise Hunter, MD | |
|
200 1st St Sw, Rochester, MN 55905-0001 | |
| (507) 284-2511 | |
| Not Available |
| Full Name | Daria Denise Hunter |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine |
| Experience | 6 Years |
| Location | 200 1st St Sw, Rochester, Minnesota |
| Accepts Medicare Assignments | May be. She may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1871172197 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 31567 (Minnesota) | Secondary |
| 207P00000X | Emergency Medicine | 71967 (Minnesota) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mayo Clinic Health System-southeast Minnesota Region | 4385556703 | 573 |
News Archive
SQI Diagnostics Inc., a life sciences company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics, today announced its financial and operational results for the third quarter ended June 30, 2011.
Mitochondria are the powerhouse of cells which continuously convert energy from food into the chemical energy currency called ATP.
Dr. David Nabarro, Assistant Secretary-General at the United Nations and co-ordinator of the Secretary-General's High-Level Task Force on the Global Food Security Crisis, will deliver the keynote address at the opening evening of the Third McGill Conference on Global Food Security on Tuesday, Oct. 19, 5 p.m., at Centre Mont-Royal, 2200 Mansfield St. in Montreal.
Acetylon Pharmaceuticals Inc., a leader in targeted epigenetic drug discovery and development for enhanced therapeutic outcomes, today announced results from a preclinical study of a selective histone deacetylase (HDAC) 1/2 inhibitor for the treatment of sickle cell disease (SCD) and beta-thalassemia (bT) at the 54th Annual Meeting of the American Society of Hematology (ASH), taking place in Atlanta, Georgia.
› Verified 6 days ago
| Entity Name | Mayo Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922074434 PECOS PAC ID: 6507778255 Enrollment ID: O20031103000285 |
News Archive
SQI Diagnostics Inc., a life sciences company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics, today announced its financial and operational results for the third quarter ended June 30, 2011.
Mitochondria are the powerhouse of cells which continuously convert energy from food into the chemical energy currency called ATP.
Dr. David Nabarro, Assistant Secretary-General at the United Nations and co-ordinator of the Secretary-General's High-Level Task Force on the Global Food Security Crisis, will deliver the keynote address at the opening evening of the Third McGill Conference on Global Food Security on Tuesday, Oct. 19, 5 p.m., at Centre Mont-Royal, 2200 Mansfield St. in Montreal.
Acetylon Pharmaceuticals Inc., a leader in targeted epigenetic drug discovery and development for enhanced therapeutic outcomes, today announced results from a preclinical study of a selective histone deacetylase (HDAC) 1/2 inhibitor for the treatment of sickle cell disease (SCD) and beta-thalassemia (bT) at the 54th Annual Meeting of the American Society of Hematology (ASH), taking place in Atlanta, Georgia.
› Verified 6 days ago
| Entity Name | Mayo Clinic Health System-lake City |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164463659 PECOS PAC ID: 1951213487 Enrollment ID: O20031104000095 |
News Archive
SQI Diagnostics Inc., a life sciences company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics, today announced its financial and operational results for the third quarter ended June 30, 2011.
Mitochondria are the powerhouse of cells which continuously convert energy from food into the chemical energy currency called ATP.
Dr. David Nabarro, Assistant Secretary-General at the United Nations and co-ordinator of the Secretary-General's High-Level Task Force on the Global Food Security Crisis, will deliver the keynote address at the opening evening of the Third McGill Conference on Global Food Security on Tuesday, Oct. 19, 5 p.m., at Centre Mont-Royal, 2200 Mansfield St. in Montreal.
Acetylon Pharmaceuticals Inc., a leader in targeted epigenetic drug discovery and development for enhanced therapeutic outcomes, today announced results from a preclinical study of a selective histone deacetylase (HDAC) 1/2 inhibitor for the treatment of sickle cell disease (SCD) and beta-thalassemia (bT) at the 54th Annual Meeting of the American Society of Hematology (ASH), taking place in Atlanta, Georgia.
› Verified 6 days ago
| Entity Name | Mayo Clinic Health System-southeast Minnesota Region |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1891701637 PECOS PAC ID: 4385556703 Enrollment ID: O20031104000408 |
News Archive
SQI Diagnostics Inc., a life sciences company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics, today announced its financial and operational results for the third quarter ended June 30, 2011.
Mitochondria are the powerhouse of cells which continuously convert energy from food into the chemical energy currency called ATP.
Dr. David Nabarro, Assistant Secretary-General at the United Nations and co-ordinator of the Secretary-General's High-Level Task Force on the Global Food Security Crisis, will deliver the keynote address at the opening evening of the Third McGill Conference on Global Food Security on Tuesday, Oct. 19, 5 p.m., at Centre Mont-Royal, 2200 Mansfield St. in Montreal.
Acetylon Pharmaceuticals Inc., a leader in targeted epigenetic drug discovery and development for enhanced therapeutic outcomes, today announced results from a preclinical study of a selective histone deacetylase (HDAC) 1/2 inhibitor for the treatment of sickle cell disease (SCD) and beta-thalassemia (bT) at the 54th Annual Meeting of the American Society of Hematology (ASH), taking place in Atlanta, Georgia.
› Verified 6 days ago
| Entity Name | Olmsted Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952356297 PECOS PAC ID: 8527970060 Enrollment ID: O20031119000240 |
News Archive
SQI Diagnostics Inc., a life sciences company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics, today announced its financial and operational results for the third quarter ended June 30, 2011.
Mitochondria are the powerhouse of cells which continuously convert energy from food into the chemical energy currency called ATP.
Dr. David Nabarro, Assistant Secretary-General at the United Nations and co-ordinator of the Secretary-General's High-Level Task Force on the Global Food Security Crisis, will deliver the keynote address at the opening evening of the Third McGill Conference on Global Food Security on Tuesday, Oct. 19, 5 p.m., at Centre Mont-Royal, 2200 Mansfield St. in Montreal.
Acetylon Pharmaceuticals Inc., a leader in targeted epigenetic drug discovery and development for enhanced therapeutic outcomes, today announced results from a preclinical study of a selective histone deacetylase (HDAC) 1/2 inhibitor for the treatment of sickle cell disease (SCD) and beta-thalassemia (bT) at the 54th Annual Meeting of the American Society of Hematology (ASH), taking place in Atlanta, Georgia.
› Verified 6 days ago
| Entity Name | Mayo Clinic Health System-lake City |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1538113022 PECOS PAC ID: 1951213487 Enrollment ID: O20070711000490 |
News Archive
SQI Diagnostics Inc., a life sciences company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics, today announced its financial and operational results for the third quarter ended June 30, 2011.
Mitochondria are the powerhouse of cells which continuously convert energy from food into the chemical energy currency called ATP.
Dr. David Nabarro, Assistant Secretary-General at the United Nations and co-ordinator of the Secretary-General's High-Level Task Force on the Global Food Security Crisis, will deliver the keynote address at the opening evening of the Third McGill Conference on Global Food Security on Tuesday, Oct. 19, 5 p.m., at Centre Mont-Royal, 2200 Mansfield St. in Montreal.
Acetylon Pharmaceuticals Inc., a leader in targeted epigenetic drug discovery and development for enhanced therapeutic outcomes, today announced results from a preclinical study of a selective histone deacetylase (HDAC) 1/2 inhibitor for the treatment of sickle cell disease (SCD) and beta-thalassemia (bT) at the 54th Annual Meeting of the American Society of Hematology (ASH), taking place in Atlanta, Georgia.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Daria Denise Hunter, MD 200 1st St Sw, Rochester, MN 55905-0001 Ph: (507) 284-2511 | Daria Denise Hunter, MD 200 1st St Sw, Rochester, MN 55905-0001 Ph: (507) 284-2511 |
News Archive
SQI Diagnostics Inc., a life sciences company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics, today announced its financial and operational results for the third quarter ended June 30, 2011.
Mitochondria are the powerhouse of cells which continuously convert energy from food into the chemical energy currency called ATP.
Dr. David Nabarro, Assistant Secretary-General at the United Nations and co-ordinator of the Secretary-General's High-Level Task Force on the Global Food Security Crisis, will deliver the keynote address at the opening evening of the Third McGill Conference on Global Food Security on Tuesday, Oct. 19, 5 p.m., at Centre Mont-Royal, 2200 Mansfield St. in Montreal.
Acetylon Pharmaceuticals Inc., a leader in targeted epigenetic drug discovery and development for enhanced therapeutic outcomes, today announced results from a preclinical study of a selective histone deacetylase (HDAC) 1/2 inhibitor for the treatment of sickle cell disease (SCD) and beta-thalassemia (bT) at the 54th Annual Meeting of the American Society of Hematology (ASH), taking place in Atlanta, Georgia.
› Verified 6 days ago
Dr. Sara Ann Schroeder Hevesi, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511 | |
David W Claypool, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511 | |
Fernanda Bellolio, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511 | |
Kristofer William Roberts, Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511 | |
Jonathan F. Thomas, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511 | |
Dr. Jessica Stanich, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511 | |
Bergthor Steinn Jonsson, CAND.MED. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511 |